NCT00648362View on ClinicalTrials.gov

Fasting Study of Glimepiride Tablets 1 mg to Amaryl® Tablets 1 mg

PHASE1CompletedINTERVENTIONAL
Enrollment

40

Participants

Timeline

Start Date

November 30, 2004

Primary Completion Date

November 30, 2004

Study Completion Date

December 31, 2004

Conditions
Healthy
Interventions
DRUG

Glimepiride Tablets 1 mg

1mg, single dose fasting

DRUG

Amaryl® Tablets 1 mg

1mg, single dose fasting

Trial Locations (1)

58104

PRACS Institute, Ltd., Fargo

Sponsors
All Listed Sponsors
lead

Mylan Pharmaceuticals Inc

INDUSTRY

NCT00648362 - Fasting Study of Glimepiride Tablets 1 mg to Amaryl® Tablets 1 mg | Biotech Hunter | Biotech Hunter